bpc-157 human studies clinical trials safety peptide Peptides: Research, Evidence & UK Guide bpc-157 evidence clinical – bpc-157 clinical trials human studies

Several safety considerations warrant careful discussion with a qualified clinician

Find out what a recent study showed in the "Building Muscle" sections of both the Protein Powders Review and the Collagen Supplements Review

Informed Consent and Patient Education Informed consent discussions for BPC-157 use should clearly communicate the investigational nature of the peptide, lack of FDA approval, limited human safety and efficacy data, and the reliance on animal studies for much of the supporting evidence

The company subsequently reoriented its business model toward TGA classification as a supplementary substance , and in parallel licensed the molecule for the osteoarthritis indication to other companies